HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (34) Citing Articles via Google Scholar Google Scholar Articles by Brown, L Articles by Sernia, C Search for Related Content PubMed PubMed Citation Articles by Brown, L Articles by Sernia, C

While there have been reports on changes in the renin–angiotensin system and angiotensin II (AT) receptors in diabetes, there is no agreement on the nature of these changes. This study has characterised specific AT receptors in the heart, kidney, liver and adrenal glands of the streptozotocin (STZ)-diabetic rat using radioligand binding studies with the radioligand ¹²⁵I-[Sar¹,Ile⁸]-angiotensin II. Left ventricular AT receptor density increased by 135% 4 weeks after treatment and by 206% 12 weeks after treatment; in the liver, AT receptor density increased by 476% (4 weeks) and 263% (12 weeks) and in the adrenal gland by 236% (4 weeks) and 109% (12 weeks). In contrast, renal AT receptor density decreased by 49% (4 weeks) and 36% (12 weeks). Competition-displacement assays with losartan, an AT1-selective ligand, showed that the proportion of AT receptor subtypes remained unchanged. STZ treatment decreased plasma angiotensinogen by 72% (4 weeks) and 67% (12 weeks) and increased plasma renin concentration after 12 weeks; plasma renin activity and aldosterone concentrations remained unchanged. Treatment with human insulin (5 U/day) attenuated changes in plasma angiotensinogen and AT receptor density except in the left ventricle. We conclude that there are major changes in AT receptors in the STZ-diabetic rat that are tissue-specific and time-dependent. Plasma angiotensinogen and renin secretion change in directions that result in the maintenance of plasma renin activity and aldosterone concentration.

Journal of Endocrinology (1997) 154, 355–362

This article has been cited by other articles:

				H. Bugger and E. D. Abel Rodent models of diabetic cardiomyopathy Dis. Model. Mech., September 1, 2009; 2(9-10): 454 - 466. [Abstract] [Full Text] [PDF]

				Z.-G. Xu, L.-N. Miao, Y.-C. Cui, Y. Jia, H. Yuan, and M. Wu Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1744 - 1752. [Abstract] [Full Text] [PDF]

				T. Kurihara, Y. Ozawa, N. Nagai, K. Shinoda, K. Noda, Y. Imamura, K. Tsubota, H. Okano, Y. Oike, and S. Ishida Angiotensin II Type 1 Receptor Signaling Contributes to Synaptophysin Degradation and Neuronal Dysfunction in the Diabetic Retina Diabetes, August 1, 2008; 57(8): 2191 - 2198. [Abstract] [Full Text] [PDF]

				T. Backlund, P. Lakkisto, E. Palojoki, T. Gronholm, A. Saraste, P. Finckenberg, E. Mervaala, I. Tikkanen, and M. Laine Activation of protective and damaging components of the cardiac renin-angiotensin system after myocardial infarction in experimental diabetes Journal of Renin-Angiotensin-Aldosterone System, June 1, 2007; 8(2): 66 - 73. [Abstract] [PDF]

				A. C. Hakam, A. H. Siddiqui, and T. Hussain Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats Am J Physiol Renal Physiol, February 1, 2006; 290(2): F503 - F508. [Abstract] [Full Text] [PDF]

				B. E. Thomas and T. J. Thekkumkara Glucose Mediates Transcriptional Repression of the Human Angiotensin Type-1 Receptor Gene: Role for a Novel Cis-acting Element Mol. Biol. Cell, October 1, 2004; 15(10): 4347 - 4355. [Abstract] [Full Text] [PDF]

				L. Raimondi, P. De Paoli, E. Mannucci, G. Lonardo, L. Sartiani, G. Banchelli, R. Pirisino, A. Mugelli, and E. Cerbai Restoration of Cardiomyocyte Functional Properties by Angiotensin II Receptor Blockade in Diabetic Rats Diabetes, July 1, 2004; 53(7): 1927 - 1933. [Abstract] [Full Text] [PDF]

				U. Kintscher and T. Unger Angiotensin II receptor expression: from maturation to pathogenesis Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R26 - R27. [Full Text] [PDF]

				D. J. van Dijk, G. Boner, S. Giler, and A. Erman Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat Journal of Renin-Angiotensin-Aldosterone System, September 1, 2001; 2(3): 193 - 198. [Abstract] [PDF]

				G. J. Wehbi, J. Zimpelmann, R. M. Carey, D. Z. Levine, and K. D. Burns Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors Am J Physiol Renal Physiol, February 1, 2001; 280(2): F254 - F265. [Abstract] [Full Text] [PDF]

				S. H. Park and H. J. Han The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells Am J Physiol Renal Physiol, February 1, 2002; 282(2): F228 - F237. [Abstract] [Full Text] [PDF]